IDH305

IDH305 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IDH305, covering 2017-10-11 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations [Phase 1]